description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
AGTGCAGATCCGTCACAGACTAAGGAGATGGCAGGCATTGACAGCTTCACTCCATGAAGGCCATCTCTGTTTCTCTCCTCCGCTTAACCAAGCTGTTGTGGTTTTTCAGCATAGTGTTGTATGTTCCATTGCTAGCTGTCCTGCTGTTTAACACAGTGTTGTATTTTTTTTCTAAATGTACATAATTAGAAAAGAAAATAACAATAGGAAGCTATGTGTATCTTCTGTGTAAAGCAGTGGCTTCACTGGAAAAATGGTGTGGCTAGCATTTCCCTTTGAGTCATGATGACAGATGGTGTGAAAACCATCTAAGTTTGCTTTTGACCATCACCTCCCAGTAGCAATTTGCTTTCATAATCCATTTAGCAATCCAGGCCTCTGTTGAAAAGATAATATGAGGGAGAAGGGAACACAT
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... HOPX(84525), HOP(84525)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Jiang Wang et al.
Oncotarget, 8(10), 17012-17026 (2017-02-16)
Bone metastases are responsible for some of the most devastating complications of renal cell carcinoma (RCC). However, pro-metastatic factors leading to the highly osteolytic characteristics of RCC bone metastasis have barely been explored. We previously developed novel bone-seeking RCC cell
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EHU064991-20UG | 04061828607648 |
| EHU064991-50UG | 04061828382620 |